Editorial: Signaling pathways behind immune evasion and therapy resistance.
Publication
, Journal Article
Martin-Orozco, E; Wang, L; Chatterjee, S; Hanks, BA
Published in: Front Immunol
2022
Duke Scholars
Published In
Front Immunol
DOI
EISSN
1664-3224
Publication Date
2022
Volume
13
Start / End Page
1104167
Location
Switzerland
Related Subject Headings
- Signal Transduction
- Immune Evasion
- Cell Line, Tumor
- Biochemical Phenomena
- 3204 Immunology
- 3105 Genetics
- 3101 Biochemistry and cell biology
- 1108 Medical Microbiology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Martin-Orozco, E., Wang, L., Chatterjee, S., & Hanks, B. A. (2022). Editorial: Signaling pathways behind immune evasion and therapy resistance. Front Immunol, 13, 1104167. https://doi.org/10.3389/fimmu.2022.1104167
Martin-Orozco, Elena, Lisheng Wang, Shilpak Chatterjee, and Brent A. Hanks. “Editorial: Signaling pathways behind immune evasion and therapy resistance.” Front Immunol 13 (2022): 1104167. https://doi.org/10.3389/fimmu.2022.1104167.
Martin-Orozco E, Wang L, Chatterjee S, Hanks BA. Editorial: Signaling pathways behind immune evasion and therapy resistance. Front Immunol. 2022;13:1104167.
Martin-Orozco, Elena, et al. “Editorial: Signaling pathways behind immune evasion and therapy resistance.” Front Immunol, vol. 13, 2022, p. 1104167. Pubmed, doi:10.3389/fimmu.2022.1104167.
Martin-Orozco E, Wang L, Chatterjee S, Hanks BA. Editorial: Signaling pathways behind immune evasion and therapy resistance. Front Immunol. 2022;13:1104167.
Published In
Front Immunol
DOI
EISSN
1664-3224
Publication Date
2022
Volume
13
Start / End Page
1104167
Location
Switzerland
Related Subject Headings
- Signal Transduction
- Immune Evasion
- Cell Line, Tumor
- Biochemical Phenomena
- 3204 Immunology
- 3105 Genetics
- 3101 Biochemistry and cell biology
- 1108 Medical Microbiology
- 1107 Immunology